1-3 of 3
Mark Yarchoan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Context-Dependent Immunomodulatory Effects of MEK Inhibition Are Enhanced with T-cell Agonist Therapy

Lauren Dennison, Amanda Ruggieri, Aditya Mohan, James Leatherman, Kayla Cruz, Skylar Woolman, Nilofer Azad, Gregory B. Lesinski, Elizabeth M. Jaffee, Mark Yarchoan
Journal: Cancer Immunology Research
Cancer Immunol Res (2021) 9 (10): 1187–1201.
https://doi.org/10.1158/2326-6066.CIR-21-0147
Published: 01 October 2021
View article titled, Context-Dependent Immunomodulatory Effects of MEK Inhibition Are Enhanced with T-cell Agonist Therapy
Open the PDF for Context-Dependent Immunomodulatory Effects of MEK Inhibition Are Enhanced with T-cell Agonist Therapy in another window
Includes: Supplementary data
Journal Articles

Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival

Ludmila Danilova, Won Jin Ho, Qingfeng Zhu, Teena Vithayathil, Ana De Jesus-Acosta, Nilofer S. Azad, Daniel A. Laheru, Elana J. Fertig, Robert Anders, Elizabeth M. Jaffee, Mark Yarchoan
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (6): 886–895.
https://doi.org/10.1158/2326-6066.CIR-18-0822
Published: 03 June 2019
View article titled, Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival
Open the PDF for Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival in another window
Includes: Supplementary data
Journal Articles

Multiple Immune-Suppressive Mechanisms in Fibrolamellar Carcinoma

Amy K. Kim, Faiz Gani, Andrew J. Layman, Sepideh Besharati, Qingfeng Zhu, Farah Succaria, Elizabeth L. Engle, Feriyl Bhaijee, Maria B. Goggins, Nicolas J. Llosa, Timothy M. Pawlik, Mark Yarchoan, Elizabeth M. Jaffee, Howard C. Simons, Janis M. Taube, Robert A. Anders
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (5): 805–812.
https://doi.org/10.1158/2326-6066.CIR-18-0499
Published: 01 May 2019
View article titled, Multiple Immune-Suppressive Mechanisms in Fibrolamellar Carcinoma
Open the PDF for Multiple Immune-Suppressive Mechanisms in Fibrolamellar Carcinoma in another window
Includes: Supplementary data